Promoting early detection tests for colorectal carcinoma and adenomatous polyps: A framework for action: The strategic plan of the National Colorectal Cancer Roundtable

Cancer

Volumn 95, Issue 8, 2002, Pages 1618-1628

  Levin, Bernard ^a   Smith, Robert A ^b   Feldman, Gabriel E ^c   Colditz, Graham A ^d   Fletcher, Robert H ^e   Nadel, Marion ^f   Rothenberger, David A ^g   Schroy, Paul S ^h   Vernon, Sally W ⁱ   Wender, Richard ^j  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

^c NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^j THOMAS JEFFERSON UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; ARTICLE; AWARENESS; CANCER DIAGNOSIS; CANCER SCREENING; COLORECTAL CARCINOMA; COST EFFECTIVENESS ANALYSIS; HEALTH CARE POLICY; MEDICAL LITERATURE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUBLISHING; VOCATIONAL EDUCATION;

ADENOMATOUS POLYPS; ADULT; AGED; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HEALTH POLICY; HEALTH PROMOTION; HUMANS; INTERPROFESSIONAL RELATIONS; MALE; MASS SCREENING; MIDDLE AGED; MOTIVATION; PATIENT COMPLIANCE; PROGRAM DEVELOPMENT;

EID: 0037108317     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10890     Document Type: Article

References (78)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47.
2. Ries L, Eisner M, Kosary C, et al. SEER Cancer Statistics Review, 1973-1998. Bethesda, MD: National Cancer Institute, 2001.
3. Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer. 2000;88:2398-2424.
4. Baquet CR, Commiskey P. Colorectal cancer epidemiology in minorities: a review. J Assoc Acad Minor Phys. 1999;10:51-58.
5. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale [see comments] [published errata appear in Gastroenterology. 1997;112:1060 and 1998;114:625]. Gastroenterology. 1997;112:594-642.
6. Tomeo CA, Colditz GA, Willett WC, et al. Harvard Report on Cancer Prevention. Volume 3: prevention of colon cancer in the United States. Cancer Causes Control. 1999;10:167-180.
7. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study [published erratum appears in N Engl J Med. 1993;329:672] [see comments]. N Engl J Med. 1993;328:1365-1371.
8. National Cancer Institute. Conquering colorectal cancer: a blueprint for the future. The report of the Colorectal Cancer Progress Review Group. Bethesda, MD: National Cancer Institute, 2000.
9. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284:1954-1561.
10. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000;133:573-584.
11. Wagner JL, Tunis J, Brown M, Ching A, Almeida R. Costeffectiveness of colorectal cancer screening in average-risk adults. In: Young G, Levin B, editors. Prevention and early detection of colorectal cancer. London: Saunders, 1996:321-356.
12. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive services task force. Ann Intern Med. 2002;137:96-104.
13. Smith RA, von Eschenbach AC, Wender R, D, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin. 2001;51:38-75; quiz, 77-80.
14. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive services task force. Ann Intern Med. 2002;137:132-141.
15. Centers for Disease Control and Prevention. Trends in screening for colorectal cancer-United States, 1997 and 1999. MMWR Morb Mortal Wkly Rep. 2001;50:162-166.
16. Centers for Disease Control. Self-reported use of mammography and insurance status among women aged > or =40 years-United States, 1991-1992 and 1996-1997. MMWR Morb Mortal Wkly Rep 1998;47:839-830.
17. Brenes GA, Paskett ED. Predictors of stage of adoption for colorectal cancer screening. Prev Med. 2000;31:410-416.
18. Mandelson MT, Curry SJ, Anderson LA, et al. Colorectal cancer screening participation by older women. Am J Prev Med. 2000;19:149-154.
19. Vernon SW. Participation in colorectal cancer screening: a review [see comments]. J Natl Cancer Inst. 1997;89:1406-1422.
20. Weitzman ER, Zapka J, Estabrook B, Goins KV. Risk and reluctance: understanding impediments to colorectal cancer screening. Prev Med. 2001;32:502-513.
21. Rawl SM, Menon U, Champion VL, Foster JL, Skinner CS. Colorectal cancer screening beliefs. Focus groups with first-degree relatives. Cancer Pract. 2000;8:32-37.
22. Peterson SK, Vernon SW. A review of patient and physician adherence to colorectal cancer screening guidelines. Semin Colon Rectal Surg. 2000;11:58-72.
23. Batelle Corporation. Evaluation of physicians' knowledge, attitudes, and practices related to screening for colorectal cancer. Atlanta, GA: American Cancer Society, 1998.
24. Cooper GS, Fortinsky RH, Hapke R, Landefeld CS. Factors associated with the use of flexible sigmoidoscopy as a screening test for the detection of colorectal carcinoma by primary care physicians. Cancer, 1998;82:1476-1481.
25. Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med. 1999;14:432-437.
26. Sharma VK, Corder FA, Fancher J, Howden CW. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test. Am J Gastroenterol. 2000;95:3629-3632.
27. Yamamoto M, Nakama H. Cost-effectiveness analysis of immunochernical occult blood screening for colorectal cancer among three fecal sampling methods. Hepatogastroenterology. 2000;47:396-399.
28. Lurie JD, Welch HG. Diagnostic testing following fecal occult blood screening in the elderly. J Natl Cancer Inst. 1999;91: 1641-1646.
29. Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001;345:555-560.
30. Winawer SJ, Stewart ET, Zauber AG, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group [see comments]. N Engl J Med. 2000;342:1766-1772.
31. Dominitz JA, Provenzale D. Patient preferences and quality of life associated with colorectal cancer screening. Am J Gastroenterol. 1997;92:2171-2178.
32. Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Pract. 1997;45:211-218.
33. Gordon NP, Rundall TG, Parker L. Type of health care coverage and the likelihood of being screened for cancer. Med Care. 1998;36:636-645.
34. Lewis JD, Asch DA. Barriers to office-based screening sigmoidoscopy: does reimbursement cover costs? Ann Intern Med. 1999;130:525-530.
35. Burke W, Petersen G, Lynch P, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. 1. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA. 1997;277:915-919.
36. Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer. 1996; 78:1149-1167.
37. Yarnall KS, Rimer BK, Hynes D, et al. Computerized prompts for cancer screening in a community health center. J Am Board Fam Pract. 1998;11:96-104.
38. McPhee SJ, Detmer WM. Office-based interventions to improve delivery of cancer prevention services by primary care physicians. Cancer. 1993;72(3 Suppl):1100-1112.
39. Walsh JM, McPhee SJ. A systems model of clinical preventive care: an analysis of factors influencing patient and physician. Health Educ Q. 1992;19:157-175.
40. McPhee SJ, Bird JA, Fordham D, Rodnick JE, Osborn EH. Promoting cancer prevention activities by primary care physicians. Results of a randomized, controlled trial. JAMA. 1991;266:538-544.
41. Bird JA, McPhee SJ, Jenkins C, Fordham D. Three strategies to promote cancer screening. How feasible is wide-scale implementation? Med Care. 1990;28:1005-1012.
42. McPhee SJ, Bird JA, Jenkins CN, Fordham D. Promoting cancer screening. A randomized, controlled trial of three interventions. Arch Intern Med 1989;149:1866-1872.
43. Dietrich AJ, Sox CH, Tosteson TD, Woodruff CB. Durability of improved physician early detection of cancer after conclusion of intervention support. Cancer. Epidemiol Biomarkers Prev 1994;3:335-340.
44. Bejes C, Marvel MK. Attempting the improbable: offering colorectal cancer screening to all appropriate patients. Fam Pract Res J. 1992;12:83-90.
45. Beeker C, Kraft JM, Southwell BG, Jorgensen CM. Colorectal cancer screening in older men and women: qualitative research findings and implications for intervention. J Community Health. 2000;25:263-278.
46. Garr DR, Ornstein SM, Jenkins RG, Zemp LD. The effect of routine use of computer-generated preventive reminders in a clinical practice. Am J Prev Med. 1993;9:55-61.
47. Hulscher ME, Wensing M, Grol RP, van der Weijden T, van Weel C. Interventions to improve the delivery of preventive services in primary care. Am J Public Health. 1999;89(5):737-746.
48. Wardle J, Sutton S, Williamson S, et al. Psychosocial influences on older adults' interest in participating in bowel cancer screening. Prev Med. 2000;31:323-334.
49. Jorgensen CM, Gelb CA, Merritt TL, Seeff LC. Observations from the CDC: CDC's Screen for Life: a National Colorectal Cancer Action Campaign. J Womens Health Gend Based Med. 2001;10:417-422.
50. Centers for Disease Control and Prevention. Screen for life, 2002. Atlanta: Centers for Disease Control and Prevention, 2002. URL: http://www.cdc.gov/cancer. ScreenForLife
51. The Advertising Council. The Advertising Council and the American Cancer Society launch PSAs to promote ealry colon cancer detection: The Advertising Council, 2002. URL: http://www.adcouncil.org/Press_Release/body_news_camp_ 012802a.html
52. Nattinger AB, Hoffmann RG, Howell-Pelz A, Goodwin JS. Effect of Nancy Reagan's mastectomy on choice of surgery for breast cancer by US women. JAMA. 1998;279:762-766.
53. Brown ML, Potosky AL. The presidential effect: the public health response to media coverage about Ronald Reagan's colon cancer episode. Public Opin Q. 1990;54:317-329.
54. Malin JL, Kahn K, Dulai G, et al. Organizational systems used by California capitated medical groups and independent practice associations to increase cancer screening. Cancer. 2000;88:2824-2831.
55. Fletcher RH, Colditz GA, Pawlson LG, Richman H, Rosenthal D, Salber PR. Screening for colorectal cancer: the business case. Am J Manag Care. 2002;8:531-538.
56. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology. 1995;109:1781-90.
57. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380 [see comments]. N Engl J Med. 2000;343: 162-168.
58. Fronstin P. The working uninsured: who they are, how they have changed, and the consequences of being uninsuredwith presidential candidate proposals outlined. EBRI Issue Brief. 2000:1-23.
59. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA. 1992;268:240-248.
60. Greer AL. The state of the art versus the state of the science. The diffusion of new medical technologies into practice. Int J Technol Assess Health Care. 1988;4:5-26.
61. Rogers EM. Diffusion of Innovations. Volume 155. New York: Free Press, 1995.
62. Rex DK. Colorectal cancer screening: a guide to the guidelines. Can J Gastroenterol. 1999;13:397-402.
63. Schneider EC, Riehl V, Courte-Wienecke S, Eddy DM, Sennett C. Enhancing performance measurement: NCQA's road map for a health information framework. National Committee for Quality Assurance. JAMA. 1999;282:1184-1190.
64. Fletcher RH, Farraye FA. Screening flexible sigmoidoscopy: effectiveness is not enough. Gastroenterology. 1999;117:486-488.
65. Schroy PC, Heeren T, Bliss CM, Pincus J, Wilson S, Prout M. Implementation of on-site screening sigmoidoscopy positively influences utilization by primary care providers. Gastroenterology. 1999;117:304-311.
66. Fleisher M, Winawer SJ, Zauber AG, Smith C, Schwartz MK. Accuracy of fecal occult blood test interpretation. National Polyp Study Work Group. Ann Intern Med. 1991;114:875-876.
67. Meyer GS, Jacoby I, Krakauer H, Powell DW, Aurand J, McCardle P. Gastroenterology workforce modeling. JAMA. 1996;276:689-694.
68. Schoenfeld P, Lipscomb S, Crook J, et al. Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: a randomized trial. Gastroenterology. 1999;117:312-318.
69. Physicians Insurers Association of America, PIAA Breast Cancer Study. Washington, DC: Physicians Insurers Association of America, 1995.
70. Selby IV, Friedman GD, Quesenberry CPJ, Weiss NS. A casecontrol study of screening sigmoidoscopy and mortality from colorectal cancer [see comments]. N Engl J Med. 1992; 326:653-657.
71. Levin TR, Palitz A, Grossman S, et al. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA. 1999;281:1611-1617.
72. Klabunde CN, Frame PS, Meadow A, Jones E, Nadel M, SW V. A national survey of primary care physicians' colorectal cancer screening recommendations and practices. National Cancer Institute. Applied research program's role in physician surveys. Rockville, VA: National Cancer Institute, 2002. URL: http://appliedresearch.cancer.gov/surveys/physician
73. Bowdy M. Lag in colorectal screening rates prompts innovation. J Natl Cancer Inst. 1998;90:886-887.
74. Fenlon HM, Nunes DP, Schroy PC 3rd, Barish MA, Clarke PD, Ferrucci JT. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med. 1999;341:1496-1503.
75. Ahlquist DA, Skoletsky JE, Boynton KA, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology. 2000;119:1219-1227.
76. Traverso G, Shuber A, Levin B, et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med. 2002;346:311-320.
77. Fletcher RH. Should all people over the age of 50 have regular fecal occult-blood tests? If it works, why not do it? N Engl J Med. 1998;338:1153-1154; discussion 54-55.
78. Cokkinides V, Chao A, Smith RA, Vernon SW, Thun MJ. Correlates of under-utilization of colorectal cancer screening tests among U.S. adults age 50 years and older. Prev Med. In press.